Ownership

Regeneron Pharmaceuticals, Inc. Ownership

Ownership for Regeneron Pharmaceuticals, Inc. (REGN) on 6ix covers company data, market context, news, risks, and AI research briefs.

websiteREGNOwnership/analysis/REGN/ownership

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to REGN.

Stock profile

Ticker

REGN

Asset type

Stock

Market cap

$63.95B

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

USD

Ticker listings

Regeneron Pharmaceuticals, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • REGN primary listing
  • RGO
  • 881535
  • REGN34
  • 0R2M
  • 1REGN
  • REGNN
  • 4REGN

Research sections

Valuation

Review valuation context for Regeneron Pharmaceuticals, Inc..

Future growth

Review future growth context for Regeneron Pharmaceuticals, Inc..

Past performance

Review past performance context for Regeneron Pharmaceuticals, Inc..

Financial health

Review financial health context for Regeneron Pharmaceuticals, Inc..

Dividend

Review dividend context for Regeneron Pharmaceuticals, Inc..

Management

Review management context for Regeneron Pharmaceuticals, Inc..

Ownership

Review ownership context for Regeneron Pharmaceuticals, Inc..

Other information

Review other information context for Regeneron Pharmaceuticals, Inc..

Community

Review community context for Regeneron Pharmaceuticals, Inc..